Weight change upon initiation of insulin detemir treatment with or without dietary intervention in insulin-naive patients with Type 2 diabetes

被引：0
|
作者：
Hollander, P. [1 ]
Piletic, M. [2 ]
Silver, H. J. [3 ]
Andersen, H. [4 ]
Hiort, L. C. [5 ]
Niswender, K. [6 ]
机构：
[1] Baylor Univ, Med Ctr, Baylor Endocrine Ctr, Dallas, TX USA
[2] Gen Hosp, Dept Diabet, Novo Mesto, Slovenia
[3] Vanderbilt Univ, Sch Med, Div Gastroenterol Hepatol & Nutr, Nashville, TN 37212 USA
[4] Novo Nordisk AS, Global Dev, DK-2880 Bagsvaerd, Denmark
[5] Novo Nordisk AS, Insulin & Devices, Biostat, DK-2880 Bagsvaerd, Denmark
[6] Vanderbilt Univ, Sch Med, Div Endocrinol Diabet & Metab, Nashville, TN 37212 USA
来源：
DIABETIC MEDICINE | 2013年 / 30卷
关键词：
D O I：
10.1111/dme.12090_15
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E6 / E6
页数：1
相关论文
共 50 条
  • [1] Weight change upon initiation of insulin detemir treatment with or without dietary intervention
    Hollander, P. A.
    Piletic, M.
    Silver, H. J.
    Andersen, H.
    Hiort, L. Conradsen
    Niswender, K.
    [J]. DIABETOLOGIA, 2012, 55 : S385 - S386
  • [2] Weight change upon once-daily initiation of insulin detemir with or without dietary intervention in overweight or obese insulin-naive individuals with type 2 diabetes: results from the DIET trial
    Niswender, K.
    Piletic, M.
    Andersen, H.
    Hiort, L. Conradsen
    Hollander, P.
    [J]. DIABETES OBESITY & METABOLISM, 2014, 16 (02): : 186 - 192
  • [3] Insulin detemir improves glycaemic control without weight gain in insulin-naive patients with type 2 diabetes:: subgroup analysis from the PREDICTIVE™ study
    Dornhorst, A.
    Lueddeke, H. -J.
    Sreenan, S.
    Kozlovski, P.
    Hansen, J. B.
    Looij, B. -J.
    Meneghini, L.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2008, 62 (04) : 659 - 665
  • [4] An analysis of the cost-effectiveness of starting insulin detemir in insulin-naive people with type 2 diabetes
    Home, Philip
    Baik, Sei Hyun
    Gonzalez Galvez, Guillermo
    Malek, Rachid
    Nikolajsen, Annie
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2015, 18 (03) : 230 - 240
  • [5] A Comparison of Insulin Use, Glycemic Control, and Health Care Costs With Insulin Detemir and Insulin Glargine in Insulin-Naive Patients With Type 2 Diabetes
    Borah, Bijan J.
    Darkow, Theodore
    Bouchard, Jonathan
    Aagren, Mark
    Forma, Felicia
    Alemayehu, Berhanu
    [J]. CLINICAL THERAPEUTICS, 2009, 31 (03) : 623 - 631
  • [6] Comparison of three algorithms for initiation and titration of insulin glargine in insulin-naive patients with type 2 diabetes mellitus
    Dailey, George
    Aurand, Lisa
    Stewart, John
    Ameer, Barbara
    Zhou, Rong
    [J]. JOURNAL OF DIABETES, 2014, 6 (02) : 176 - 183
  • [7] Self-reported impressions of insulin detemir among patients with type 2 diabetes: Insulin-naive vs. prior insulin users
    Kerney, Donna L.
    Paradis, Diana
    Lucrezia, Laurel
    Brunton, Stephen
    [J]. DIABETES, 2007, 56 : A537 - A537
  • [8] A randomized, treat-to-target trial comparing insulin lispro protamine suspension and insulin detemir in insulin-naive patients with Type 2 diabetes
    Fogelfeld, L.
    Dharmalingam, M.
    Robling, K.
    Jones, C.
    Swanson, D.
    Jacober, S.
    [J]. DIABETIC MEDICINE, 2010, 27 (02) : 181 - 188
  • [9] Prospective 1 year observational study of insulin glargine initiation in 103 insulin-naive patients with type 2 diabetes
    Tadros, Labib
    Barnes, E.
    Ledger-Scott, M.
    Murphy, J.
    Jeavons, D.
    Byrne, H.
    Gray, A.
    Nayman, D.
    Pearson, S.
    [J]. DIABETES, 2007, 56 : A146 - A146
  • [10] SMART INSULIN THERAPY INITIATION IMPROVES GLUCOSE CONTROL IN INSULIN-NAIVE SUBJECTS WITH TYPE 2 DIABETES
    Bonet, J.
    Visentin, R.
    Vettoretti, M.
    Facchinetti, A.
    Man, C. Dalla
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A85 - A85
12345